Evidence map›Paper›PMID 33997466›Full record

ArticleAmerican journal of ophthalmology case reports2021

Anti-myelin oligodendrocyte glycoprotein antibodies in a girl with good recovery after five episodes of prior idiopathic optic neuritis.

Mathias Falck Schmidt, Gorm Pihl-Jensen, Margrethe Bastholm Bille, Jette Lautrup Frederiksen

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mathias Falck SchmidtClinic of Optic Neuritis, The Danish Multiple Sclerosis Center (DMSC), Department of Neurology, Rigshospitalet - Glostrup, University of Copenhagen, Valdemar Hansens Vej 13, 2600, Glostrup, Denmark.
Gorm Pihl-JensenClinic of Optic Neuritis, The Danish Multiple Sclerosis Center (DMSC), Department of Neurology, Rigshospitalet - Glostrup, Valdemar Hansens Vej 13, 2600, Glostrup, Denmark.
Margrethe Bastholm BilleDepartment of Neurophysiology, Rigshospitalet, Valdemar Hansens Vej 13, 2600, Glostrup, Denmark.
Jette Lautrup FrederiksenClinic of Optic Neuritis, The Danish Multiple Sclerosis Center (DMSC), Department of Neurology, Rigshospitalet - Glostrup, University of Copenhagen, Valdemar Hansens Vej 13, 2600, Glostrup, Denmark.
University of Copenhagen · DKGlostrup Hospital · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe the clinical, radiological, immunological and electrophysiological features of a myelin oligodendrocyte glycoprotein (MOG)-IgG positive girl with five prior episodes of idiopathic bilateral optic neuritis (ON). OBSERVATIONS: We report a Danish girl who has been followed by pediatricians and pediatric neurologists since the age of 10 with recurrent episodes of idiopathic bilateral ON. Since the age of 15 there has been no recurrence of ON, and the patient has been thoroughly investigated for Multiple Sclerosis (MS) several times, but with negative findings. At the age of 19 the patient was referred to the Clinic of Optic Neuritis where she was tested seropositive for antibodies against MOG (MOG- IgG) on a conventionally cell-based assay. Despite 5 previous episodes of ON, the latency and amplitude signals of pattern-reversal visual evoked potentials (pVEP) including multifocal VEP were detected within the normal range.

conclusionThe clinical implications of MOG- IgG are not yet clear, but in cases where the diagnosis of MS is less likely and where ON is the main symptom, testing for both IgG antibodies against AQP4 and MOG while having atypical optic neuropathies in mind is important. MOG-IgG positive patients may have a good prognosis with regards to visual function.

Indexed as

Multiple sclerosis (MS)Myelin oligodendrocyte glycoprotein (MOG)Neuromyelitis optica spectrum disorder (NMOSD)Optic neuritis (ON)Visual evoked potentials (VEP)

Identifiers

PMID33997466
PMCPMC8100534
OpenAlexW3137824790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.